(CercleFinance.com) – Futures on the CAC40 foreshadow an opening on a timid rise of around 0.1 or 0.2%, towards 6560 points, to start a week which promises to be particularly busy on the stock market. macroeconomic data.
No data is scheduled for Monday, but the following days will see the release, in Europe, of the European Commission’s ESI indices, the PMI manufacturing indices, inflation and the unemployment rate in the euro zone, or even the growth of the British GDP.
In the United States, the ADP survey on private employment, the latest estimate of economic growth, household income and expenditure, the ISM manufacturing index and the employment report from the Department of Labor are expected.
“With the interest rate market appearing at the heart of the concerns, the attention should focus this week more particularly on the American employment, but the European inflation could also be watched very closely”, warns Deutsche Bank.
Regarding the publications of expected results, the calendar includes those of the Scandinavian clothing chain H&M, the French services group Sodexo, as well as the American pharmacy chain Walgreens Boots Alliance.
So far, Sanofi has shared late-breaking Phase III data presented at the 2022 AAD Congress showing that its Dupixent (dupilumab) significantly improves the signs and symptoms of nodular prurigo.
Reacting to the IGAS and IGF report, Orpea declared that it was already undertaking a series of corrective actions, while emphasizing that this report ‘allows us to conclude that there is no organized ‘system’ which would result in widespread mistreatment’.
Savencia indicates that its board of directors has chosen Olivier Delamea to succeed as general manager to Jean-Paul Torris, who has decided to leave his operational functions, which he has held since 2016, to retire.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
